Tag: Bioinformatics
Search News
International study reveals four distinct types of oesophageal cancer
23rd October 2024
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
Read more
Dr Mirjana Efremova awarded £1m Cancer Research UK grant to decode bowel cancer’s plastic nature
14th December 2023
Congratulations to Dr Mirjana Efremova who has been awarded a £1m grant to use cutting-edge computational tools to study how bowel cancer adapts.
Read more
New tool predicts risk of skin cancer spread more accurately than human inspection
12th October 2023
These results could aid the treatment of individuals most at risk of aggressive skin cancer.
Read more
Welcoming Professor Francesca Ciccarelli to the BCI
24th April 2023
Professor Francesca Ciccarelli will be joining Barts Cancer Institute to lead our Centre for Cancer Genomics & Computational Biology.
Read more
BCI researcher part of Strategic Collaboration Agreement with Queen Mary, Envisagenics and Cancer Research Horizons
14th December 2022
BCI’s Dr Ana Rio-Machin is part of a new research collaboration agreement that will leverage Envisagenics’ SpliceCore® AI platform for expanded discovery and research in haematopoietic cancers.
Read more
OPTIMA: Improving treatment for cancer patients through artificial intelligence
12th October 2021
Professors Claude Chelala and Louise Jones from Barts Cancer Institute, Queen Mary University of London, are part of a €21.3 million public-private research programme that will seek to use artificial intelligence to improve care for patients with prostate, breast and lung cancer.
Read more